id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-P-0073-0006,FDA,FDA-2006-P-0073,"Letter from FDA CDER to Ropes & Gray, LLP",Other,Letter(s),2008-11-20T05:00:00Z,2008,11,2008-11-20T05:00:00Z,,2024-10-28T14:09:44Z,,0,0,09000064807b3f96
FDA-2006-P-0073-0005,FDA,FDA-2006-P-0073,Citizen Petition Supplement from AstraZeneca LP [Ropes & Gray],Other,Supplement (SUP),2008-10-10T04:00:00Z,2008,10,2008-10-10T04:00:00Z,,2024-10-28T14:04:25Z,,0,0,09000064807445c3
FDA-2006-P-0073-0004,FDA,FDA-2006-P-0073,Citizen Petition Supplement from AstraZeneca LP [Ropes & Gray],Other,Supplement (SUP),2008-09-24T04:00:00Z,2008,9,2008-09-24T04:00:00Z,,2024-10-28T14:02:39Z,,0,0,090000648070e8da